INCY

#597
Incyte Genomics Inc
97.52 USD
+2.06%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
95.76
97.52
Rango anual
56.13
112.29
Cambio diario
+2.06%
Variación mensual
+5.80%
Variación en los últimos 6 meses
+14.55%
Cambio anual
+66.30%
Cierres anteriores
95.55
Abrir
95.76
Bid
Ask
Mínimo
95.76
High
97.52
Volumen
56
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 19.41 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.41
Relación precio/flujo de caja
3.86

Incyte Corporation

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

Noticias